Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Forum of Clinical Oncology
Volume 10 (2019): Issue 2 (December 2019)
Open Access
Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology
Evangelos Karamitrousis
Evangelos Karamitrousis
Department of Medical Oncology, Democritus University of Thrace
Alexandroupolis, Greece
Search for this author on
Sciendo
|
Google Scholar
Karamitrousis, Evangelos
,
Michalis Liontos
Michalis Liontos
Department of Clinical Therapeutics, Alexandra Hospital
Athens, Greece
Search for this author on
Sciendo
|
Google Scholar
Liontos, Michalis
and
Nikolaos Tsoukalas
Nikolaos Tsoukalas
Department of Oncology, 401 General Military Hospital
Athens, Greece
Search for this author on
Sciendo
|
Google Scholar
Tsoukalas, Nikolaos
Apr 05, 2020
Forum of Clinical Oncology
Volume 10 (2019): Issue 2 (December 2019)
About this article
Previous Article
Next Article
Article
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Article Category:
Editorial
Published Online:
Apr 05, 2020
Page range:
1 - 1
DOI:
https://doi.org/10.2478/fco-2019-0008
Keywords
© 2019 Evangelos Karamitrousis et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
